- Facultat de Medicina
Centro
![Foto de Antonio](/img/nophoto.png)
Antonio
Llombart Cussac
Publicaciones en las que colabora con Antonio Llombart Cussac (13)
2020
-
An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study
Gynecologic Oncology, Vol. 159, Núm. 3, pp. 721-731
2018
-
Circulating tumor cells (CTCs) and cytokeratin 19 (CK19) mRNA as prognostic factors in heavily pretreated patients with metastatic breast cancer
Cancer Treatment and Research Communications, Vol. 16, pp. 13-17
2017
-
Novel biomarkers in primary breast core biopsies to predict poor response to neoadjuvant chemotherapy and appearance of metastases
Histology and Histopathology, Vol. 32, Núm. 9, pp. 909-915
2014
-
Combinatorial therapy using dovitinib and ICI182.780 (Fulvestrant) blocks tumoral activity of endometrial cancer cells
Molecular Cancer Therapeutics, Vol. 13, Núm. 4, pp. 776-787
2013
-
Gene expression microarray-based assay to determine tumor site of origin in a series of metastatic tumors to the ovary and peritoneal carcinomatosis of suspected gynecologic origin
Human Pathology, Vol. 44, Núm. 1, pp. 20-28
-
Human Papillomavirus in Non-Small-Cell Lung Cancer: The Impact of EGFR Mutations and the Response to Erlotinib
Archivos de Bronconeumologia, Vol. 49, Núm. 2, pp. 79-81
2012
-
Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells
Molecular Oncology, Vol. 6, Núm. 5, pp. 530-541
-
Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA
Virchows Archiv, Vol. 460, Núm. 6, pp. 569-575
-
Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway
International Journal of Cancer, Vol. 130, Núm. 4, pp. 967-978
2010
-
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
British Journal of Cancer, Vol. 102, Núm. 10, pp. 1468-1473
2008
-
Antioxidants block proteasome inhibitor function in endometrial carcinoma cells
Anti-Cancer Drugs, Vol. 19, Núm. 2, pp. 115-124
-
Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines
British Journal of Dermatology, Vol. 158, Núm. 3, pp. 496-504
-
Targeted therapies in gynecologic cancers and melanoma
Seminars in Diagnostic Pathology, Vol. 25, Núm. 4, pp. 262-273